Pharmaceutical manufacturing industry

Pharmaceutical manufacturing industry
Industry characteristics
  • High R&D investment: As an industry driven by innovation, the development of new drugs is a lengthy process with high costs and a significant risk of failure. 


  • Strong policy supervision: From research and development, clinical trials, production to sales and distribution, all are subject to strict supervision by the national drug regulatory authorities (such as GMP). 


  • Quality requirements are extremely strict: There are nearly unrelenting demands for product purity, stability and consistency. Quality is the lifeline. 


  • High profits with high risks: Patented drugs enjoy a period of market exclusivity and high profits, but after the patent cliff, profits will plummet sharply. 


  • High market entry barriers: New products need to go through complex approval and bidding processes before they can enter the market. 


  • The demand is relatively rigid: The product is related to people's health, and the market demand is less affected by macroeconomic fluctuations and has a relatively low elasticity.


Digital transformation goals
Level One (Initial Level)

Assessment levels for the digitalization level of small and medium-sized enterprises:

Digitalization foundation, management and effectiveness ≥ 20 points;

Digitalization business application scenarios should be no less than 6 scenarios (among which no less than 3 should be restrictive scenarios) The level must reach level one

Level 2 (Standard Level)

Assessment levels for the digitalization level of small and medium-sized enterprises:

Digitalization foundation, management and effectiveness ≥ 40 points;

Digitalization business application scenarios should be no less than 6 scenarios (among which no less than 3 are restrictive scenarios) and the level must reach level 2.

Level 3 (Integration Level)

Assessment levels for the digitalization level of small and medium-sized enterprises:

Digitalization foundation, management and effectiveness ≥ 60 points;

Digitalization business application scenarios should be no less than 8 scenarios (among which no less than 5 are restrictive scenarios) The level must reach level three

Level Four (Collaborative Level)

Assessment levels for the digitalization level of small and medium-sized enterprises:

Digitalization foundation, management and effectiveness ≥ 80 points;

Digitalization business application scenarios should be no less than 10 scenarios (among which there should be no less than several restrictive scenarios) The level must reach level four

Solution

With the "Small, Fast, Lightweight and Precise" management series, we provide small and medium-sized manufacturing enterprises with lightweight, simple, efficient and precisely adapted production operation management solutions.

image.png

Typical case
Hebei Pushida Medical Devices
Hebei Pushida Medical Devices
Fujian Longmei Medical Clinic
Fujian Longmei Medical Clinic
Hebei Chengshengtang Biomedical Co., Ltd.
Hebei Chengshengtang Biomedical Co., Ltd.
Hebei Guangrui Biopharmaceuticals
Hebei Guangrui Biopharmaceuticals
Hebei Meihuo Pharmaceutical Company
Hebei Meihuo Pharmaceutical Company
Hebei Shenlong Medicine Company
Hebei Shenlong Medicine Company
Hebei Xinhua Kexi Veterinary Medicine
Hebei Xinhua Kexi Veterinary Medicine
Inner Mongolia Kaimeng Pharmaceutical Company
Inner Mongolia Kaimeng Pharmaceutical Company
Shijiazhuang Yunhai Chemical Industry
Shijiazhuang Yunhai Chemical Industry
Sichuan Suma New Materials
Sichuan Suma New Materials
Sichuan Tuojiang Source Pharmaceutical Company
Sichuan Tuojiang Source Pharmaceutical Company